Equity
argenx SE (ARGX) perpetual futures
argenx SE is a biotechnology company developing therapies for autoimmune diseases, led by its efgartigimod program and marketed under brands such as VYVGART and VYVGART HYTRULO.
+0.8%NASDAQ closed
Price chart
Interactive TradingView chart
TradingView symbol NASDAQ:ARGX
Loads TradingView's third-party widget (about 1 MB) on demand.
Auto: underlying reference priceOpen in TradingView
Trading data
Perpetual market activity
0/1 live markets
Trading data
Perpetual market activity
Venues
1
Live markets
0/1
24h volume
-
Open interest
-
Best liquidity
-
Tightest spread
-
Highest volume
-
Settlement mix
USDT · 1/1
Perp/spot vol.
-
OI / float
-
Spot performance
1D+0.79%
5D-2.00%
1M-16.63%
6M-1.06%
YTD-1.82%
1Y-2.81%
BingXBest venues for this underlying
Best liquidity
-No live data-
Tightest spread
-No live data-
Highest volume
-No live data-
Company data
Company fundamentals
Updated 1h ago
Company data
Company fundamentals
Market cap
$51.7B
Updated 1h ago
Revenue
$6B
Trailing 12 months
Revenue growth
+49%
Next fiscal year
Profit margin
+32.9%
P/E
30.4
Peer P/E 40.9
Free cash flow
$1.2B
Trailing 12 months
More metrics
Net income
$1.9B
Trailing 12 months
P/S
8.6
Peer P/E
40.9
Similar listed perps
Revenue estimate
$6.2B
Next fiscal year
Earnings
2027-03-04
Revenue est. $3.3B · Updated 1h ago
Dividend
-
Fundamental detail
Annual + quarterlyLatest revenue$4.2B
Net margin+31.1%
Free cash flow$844.3M
Net debt-$3.4B
PeriodRevenueGrowthNet incomeFCF
2020$46.3M-47%-$682.5M-$452.7M
2021$1.1B+2,230%-$408.3M-$728.2M
2022$410.7M-62%-$709.6M-$966.6M
2023$1.2B+199%-$295.1M-$464.1M
2024$2.2B+79%$833M-$151M
2025$4.2B+90%$1.3B$844.3M
PeriodGross marginOperating marginNet marginROEROA
2020+100.0%-1,158.1%-1,475.3%-36.3%-26.7%
2021+46.1%-32.4%-37.9%-16.1%-14.3%
2022+92.8%-175.4%-172.8%-25.2%-22.6%
2023+90.4%-34.7%-24.1%-7.2%-6.5%
2024+89.6%-1.0%+38.0%+15.2%+13.4%
2025+89.1%+25.4%+31.1%+17.6%+14.9%
PeriodCashDebtNet debtCurrent ratio
2020$1.4B$10.8M-$1.4B6.26
2021$1.3B$11.5M-$1.3B8.44
2022$800.7M$12.4M-$788.3M9.18
2023$2B$20M-$2B9.75
2024$1.5B$39.1M-$1.5B7.29
2025$3.5B$83.5M-$3.4B5.23
PeriodMarket capEnterprise valueP/SP/E
2020$12.3B$10.9B264.9-18.0
2021$17.9B$16.6B16.6-43.8
2022$20.6B$19.8B50.2-29.0
2023$21.7B$19.7B17.7-73.7
2024$36.8B$35.4B16.844.2
2025$51.5B$48.1B12.439.8
PeriodRevenueGrowthNet incomeFCF
Q4 2022$312.7M+1,066%-$255.6M-$344.6M
Q2 2023$510.9M+359%-$112.9M-$259M
Q4 2023$329.8M+5%-$72.6M-$135.2M
Q2 2024$401M-22%-$61.6M-$125.5M
Q4 2024$573.2M+74%$91.4M$40.9M
Q2 2025$948M+136%$245.4M$432.6M
Q4 2025$3.2B+459%$1B$406.9M
Q2 2026$2.8B+197%$838.8M$748.7M
PeriodGross marginOperating marginNet marginROEROA
Q4 2022-24.8%-109.1%-81.7%-9.1%-8.2%
Q2 2023+180.9%-40.3%-22.1%-4.0%-3.5%
Q4 2023+89.1%-24.4%-22.0%-1.8%-1.6%
Q2 2024+89.2%-23.3%-15.4%-1.4%-1.3%
Q4 2024+89.7%+2.5%+15.9%+1.7%+1.5%
Q2 2025+88.3%+21.5%+25.9%+4.0%+3.4%
Q4 2025+89.4%+26.5%+32.7%+14.3%+12.1%
Q2 2026+90.1%+30.1%+29.8%+10.0%+8.4%
PeriodCashDebtNet debtCurrent ratio
Q4 2022$800.7M$12.4M-$788.3M9.18
Q2 2023$1.1B$11.2M-$1.1B8.47
Q4 2023$2B$20M-$2B9.75
Q2 2024$1.4B$34M-$1.4B8.53
Q4 2024$1.5B$39.1M-$1.5B7.29
Q2 2025$2.1B$43.2M-$2B5.60
Q4 2025$3.5B$83.5M-$3.4B5.23
Q2 2026$3.6B$47M-$3.5B5.12
PeriodMarket capEnterprise valueP/SP/E
Q4 2022$21B$20.2B67.0-20.5
Q2 2023$21.7B$20.6B42.5-48.0
Q4 2023$22.1B$20.1B67.1-76.1
Q2 2024$25.8B$24.3B64.2-104.4
Q4 2024$37B$35.5B64.5101.2
Q2 2025$33.6B$31.6B35.520.1
Q4 2025$51.7B$48.2B16.114.8
Q2 2026$57.7B$54.2B20.517.2
Refreshed 1h ago
Charts: revenue, profit, cash flow & valuation
CashDebt
Gross marginOperating marginNet margin
P/EP/S
CashDebt
Gross marginOperating marginNet margin
P/EP/S
Next catalyst
Catalysts
Next catalyst
Catalysts
Earnings
2027-03-04
Revenue est. $3.3B · Updated 1h ago
No unusual perp activity right now.
Research data
Analysts, filings and peer context
Research data
Analysts, filings and peer context
Estimates
6DateEPS estimateRevenue estimateGrowthAnalysts
FY 202629.34$6.2B+49%8
FY 202739.01$7.7B+85%8
FY 202848.28$9.1B+118%6
FY 202961.96$10.7B+158%5
FY 203073.87$12.3B+197%5
Q4 20268.05$1.8B-44%4
Company events
62027-03-04EarningsActual - / Estimate 8.05-
2026-07-23EarningsActual 7.32 / Estimate 6.27Beat
2026-05-07EarningsActual 5.9 / Estimate 5.16Beat
2025-10-30EarningsActual 5.18 / Estimate 4.37Beat
2025-05-08EarningsActual 2.58 / Estimate 2.32Beat
2024-10-31EarningsActual 1.39 / Estimate 0.1Beat
Peer comparison
Similar listed perpsRevenue mix
PendingSegment data is not available yet.
Analysts
PendingNo analyst data available yet.
Ownership
ARGX-PERPOwnership data is being populated.
Filings
PendingNo filings available yet.
Transcripts
PendingNo transcripts available yet.
Company news
Reuters, WSJ, Bloomberg and FT first, as far as our news provider delivers them; other publishers behind the second filter. Headlines link to the publisher.No articles from Reuters, WSJ, Bloomberg or FT for this company in our feed.
Analyst track record
How the analysts covering ARGX have done: ratings, price-target accuracy and the measured reaction after their calls.
| 12 months | 3 years | |
|---|---|---|
| Ratings | 191 | 585 |
| Analysts | 28 | 39 |
| Buy / hold / sell | 178 / 13 / 0 | 527 / 57 / 1 |
| Upgrades / downgrades / initiations | 1 / 2 / 2 | 7 / 7 / 7 |
| Price targets hit / missed | 2 / 165 (1%) | 315 / 188 (63%) |
| Avg. return after a rating (TipRanks) | -21.8% | +18.3% |
| Best / worst call | +5.6% / -41.7% | +138.6% / -41.7% |
After buy calls on this stock: not enough measured cases yet
Latest ratings
| Date | Analyst | Call | Target | |
|---|---|---|---|---|
| Oct 20, 2026 | Luca IssiRBC Capital | BuyReiterated | $1,025 | |
| Oct 14, 2026 | Derek ArchilaWells Fargo | BuyReiterated | $1,356 | article ↗ |
| Oct 13, 2026 | David NierengartenWedbush | BuyMaintained | $1,130 | article ↗ |
| Oct 12, 2026 | Leland GershellOppenheimer | BuyMaintained | $1,038 | article ↗ |
| Oct 13, 2026 | Tazeen AhmadBank of America Securities | BuyMaintained | $1,157 | article ↗ |
TipRanks data via FMP · computed Oct 20, 2026 · 191 ratings
Embed this asset
<a href="https://perpequities.com/stocks/argx-perp"><img src="https://perpequities.com/badge/argx-perp.svg" width="240" height="64" alt="ARGX perpetuals · perpequities.com" loading="lazy"></a>